Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1998

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Preliminary analysis of a multicenter clinical trial using Multiload Cu

375SL for emergency contraception.

AUTHORS

Zhou L; Xiao B

SOURCE

ADVANCES IN CONTRACEPTION. 1998 Dec;14(4):161-70.

ABSTRACT

The efficacy, safety, and acceptability of use of the Multiload Cu 375 SL IUD for emergency contraception were

investigated in 515 Chinese women who had the device inserted within 5 days of unprotected intercourse. 428

women (83.1%) were parous. The most commonly used contraceptive methods were condoms and periodic

abstinence. Contraceptive failure (e.g., condom breakage or failure to withdraw) was the reason for the request for

emergency contraception in the majority (57%) of cases. The average interval between unprotected sex and IUD

insertion was 45.7 hours. Two pregnancies were reported in this series (0.39/100 women), one of which was

considered to represent user failure. The efficacy rate was 92.4%. The most common side effects were pain and

bleeding. No pelvic infections occurred. 14.9% of nulliparous and 3.5% of parous women requested IUD removal

after the resumption of menses. This study is ongoing and will eventually encompass 1000 women presenting to

family planning clinics in China for emergency contraception. (PubHealth.info Document ID: CONT2T 49-06)

PubHealth.info NOTE: The author(s) of this article titled, "Preliminary analysis of a multicenter clinical trial using

Multiload Cu 375SL for emergency contraception.", is(are) Zhou L; Xiao B. The source of this article is

"ADVANCES IN CONTRACEPTION. 1998 Dec;14(4):161-70.". This article was published in 1998 in English

language(s). (PubHealth.info® Document ID: CONT2T 49-06. All rights reserved with PubHealth.info) PIN: 5049

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.